----

----

| (Mark One)  |
|------------------|
| þ           | Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 |
|             |   |
|             | For the fiscal year ended October 31, 2015 |
|             |   |
| OR               |
|             |   |
| o                | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|             |   |
|             | For the Transition Period from         to           |

| DELAWARE                                                      | 06-1529524                          |
|---------------------------------------------------------------|-------------------------------------|
| (State or other jurisdiction ofincorporation or organization) | (I.R.S. EmployerIdentification No.) |

| Common Stock, Par Value $0.001(Title of class) |   | NASDAQ Capital Market(Name of exchange on which registered) |
|------------------------------------------------|--------|-------------------------------------------------------------|

| Large accelerated filer o | Accelerated filer o                      | Non-accelerated filer o | Smaller reporting company þ |
|--------------------------------|-----------------------------------------------|------------------------------|---------------------------------------|
|                           | (Do not check if a smaller reporting company) |

----

----

----

----

| Name             |   | Age |   | Position with the Company                                |
|------------------|--------|-----|--------|----------------------------------------------------------|
| Barry Honig      |   | 44  |   | Chairman, Chief Executive Officer and Class III Director |
| Michael Brauser  |   | 60  |   | Co-Chairman and Class II Director                        |
| John Stetson     |   | 30  |   | Chief Financial Officer                                  |
| Edward Karr      |   | 46  |   | Class I Director                                         |
| Andrew Kaplan    |   | 49  |   | Class II Director                                        |
| Mohit Bhansali   |   | 41  |   | Class III Director                                       |
| David Rector     |   | 69  |   | Class I Director                                         |
| Michael Beeghley |   | 49  |   | Class III Director                                       |

----

----

----

----

| Director          |   |   | Board    |   |   | AuditCommittee |   |   | CompensationCommittee |   |   | Nominating andGovernance Committee |
|-------------------|--------|--------|----------|--------|--------|----------------|--------|--------|-----------------------|--------|--------|------------------------------------|
| Barry Honig       |   |   | Chair    |   |   |           |   |   |                  |   |   |                               |
| Michael Brauser   |   |   | Co-Chair |   |   |           |   |   |                  |   |   |                               |
| Edward Karr*      |   |   | X        |   |   | Chair          |   |   | X                     |   |   |                               |
| Andrew Kaplan *   |   |   | X        |   |   | X              |   |   | Chair            |   |   | Chair                         |
| Mohit Bhansali*   |   |   | X        |   |   | X              |   |   |                  |   |   |                               |
| David Rector      |   |   | X        |   |   |           |   |   |                  |   |   |                               |
| Michael Beeghley* |   |   | X        |   |   |           |   |   |                  |   |   | X                             |
| Meetings in 2015: |   |   | 18       |   |   | 6              |   |   | 2                     |   |   | 0                                  |

----

|   | ● | Annually reviewing and setting compensation of executive officers; |
|--------|---------|--------------------------------------------------------------------|

|   | ● | Periodically reviewing and making recommendations to the Board with respect to compensation of non-employee directors; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------|

|   | ● | Reviewing and approving corporate goals and objectives relevant to Chief Executive Officer compensation, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, and setting the Chief Executive Officer’s compensation levels based on this evaluation; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | Reviewing competitive practices and trends to determine the adequacy of the executive compensation program; |
|--------|---------|-------------------------------------------------------------------------------------------------------------|

|   | ● | Approving and overseeing incentive compensation and equity-based plans for executive officers that are subject to Board approval; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------|

----

|   | ● | Making recommendations to the Board as to the Company’s compensation philosophy and overseeing the development and implementation of compensation programs; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | Periodically reviewing and making recommendations to the Board with respect to compensation of non-employee directors; |
|--------|---------|------------------------------------------------------------------------------------------------------------------------|

|   | ● | Reviewing and approving corporate goals and objectives relevant to Chief Executive Officer compensation, evaluating the Chief Executive Officer’s performance in light of those goals and objectives, and setting the Chief Executive Officer’s compensation levels based on this evaluation; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name and Principal Position                                           |   | Year   |   | Salary($) |   | Bonus($) |    | Stock Awards(1)($) |   | Option Awards(2)($) |   | Non-EquityIncentivePlanCompensation(3) ($) |   | All OtherCompensation(4) ($) |    | Total($) |
|-----------------------------------------------------------------------|--------|--------|--------|-----------|--------|----------|---------|--------------------|--------|---------------------|--------|--------------------------------------------|--------|------------------------------|---------|----------|
| Jesse Sutton,                                                         |   |   | 2014   |      |   |     | 363,000 |               |   |                |   |                                       |   |                         | -0-     |     |   |   | -0- |   |   |   |   |   | 13,859 | (11) |   |   | 376,859 |   |
| Chief Executive Officer (5)                                           |   |   | 2015   |      |   |     | 273,646 |               |   |                |   |                                       |   |                         | 15,841  | (14)     |   |   | 30,546 | (19) |   |   |   |   | 513,859 | (12) |   |   | 833,892 |   |
|                                                                  |   |   |   |      |   |     |    |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Michael Vesey                                                         |   |   | 2014   |      |   |     | 300,000 |               |   |                |   |                                       |   |                         | -0-     |     |   |   | -0- |   |   |   |   |   | -0- |   |   |   | 300,000 |   |
| Chief Financial Officer (6)                                           |   |   | 2015   |      |   |     | 140,770 |               |   |                |   |                                       |   |                         | 46,560  | (15)     |   |   | 14,684 | (20) |   |   |   |   | 305,900 | (13) |   |   | 507,914 |   |
|                                                                  |   |   |   |      |   |     |    |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| John Stetson                                                          |   |   | 2014   |      |   |     | -0-     |               |   |                |   |                                       |   |                         | -0-     |     |   |   |   |   |   |   |   |   |   |   |   |   | -0- |   |
| Chief Financial Officer (7)                                           |   |   | 2015   |      |   |     | 8,308   |               |   |                |   |                                       |   |                         | 372,000 | (16)     |   |   |   |   |   |   |   |   |   |   |   |   | 380,308 |   |
|                                                                  |   |   |   |      |   |     |    |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Barry Honig                                                           |   |   | 2014   |      |   |     | -0-     |               |   |                |   |                                       |   |                         | -0-     |     |   |   |   |   |   |   |   |   |   |   |   |   | -0- |   |
| Chief Executive Officer and Co-Chairman of the Board of Directors (8) |   |   | 2015   |      |   |     | 8,308   |               |   |                |   |                                       |   |                         | 496,000 | (17)     |   |   |   |   |   |   |   |   |   |   |   |   | 504,308 |   |
|                                                                  |   |   |   |      |   |     |    |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| David Rector                                                          |   |   | 2014   |      |   |     | -0-     |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Chief Executive Officer (9)                                           |   |   | 2015   |      |   |     | 6,708   |               |   |                |   |                                       |   |                         | 116,000 | (18)     |   |   | 6,273 | (21) |   |   |   |   |   |   |   |   | 128,981 |   |
|                                                                  |   |   |   |      |   |     |    |               |   |                |   |                                       |   |                         |    |     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Gary Anthony                                                          |   |   | 2014   |      |   |     | 145,500 |               |   |                | 12,000 |                                       |   |                         | -0-     |     |   |   |   |   |   |   |   |   |   |   |   |   | 157,500 |   |
| Chief Accounting Officer (10)                                         |   |   | 2015   |      |   |     | 89,200  |               |   |                | 30,000 |                                       |   |                         | 28,000  | (22)     |   |   |   |   |   |   |   |   |   |   |   |   | 147,500 |   |

----

| (1)   | Represents the aggregate grant date fair value for restricted stock awards granted during fiscal years 2014 and 2015, respectively, computed in accordance with FASB ASC Topic 718. See Note 12 to our consolidated financial statements reported in our Annual Report on Form 10-K for our fiscal year ended October 31, 2015 for details as to the assumptions used to determine the grant date fair value of the restricted stock awards. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | Represents the aggregate grant date fair value for option awards granted during fiscal years 2014 and 2015, respectively, computed in accordance with FASB ASC Topic 718. See Note 12 to our consolidated financial statements reported in our Annual Report on Form 10-K for our fiscal year ended October 31, 2015 for details as to the assumptions used to determine the grant date fair value of the option awards. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | Represents amounts paid to named executive officers in the applicable year pursuant to the Company’s STI Plan.  |
|-----------------|----------------------------------------------------------------------------------------------------------------------------|

| (4)   | Represents health and dental insurance premiums in excess of coverage provided to other employees. |
|-----------------|----------------------------------------------------------------------------------------------------|

| (5)   | Resigned on July 27, 2015 |
|-----------------|---------------------------|

| (6)   | Resigned on March 17, 2015 |
|-----------------|----------------------------|

| (7)   | Appointed on September 25, 2015 |
|-----------------|---------------------------------|

| (8)   | Appointed on September 25, 2015 |
|-----------------|---------------------------------|

| (9)   | Served as Chief Executive Officer from July 27, 2015 until September 25, 2015 |
|-----------------|-------------------------------------------------------------------------------|

| (10)   | Served as Chief Accounting Officer from April 1, 2015 to September 25, 2015, prior to this beginning May 2011, he served as the Company’s Corporate Controller. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (11)   | Represents $13,859 paid for health and dental insurance premiums in excess of coverage provided to other employees |
|------------------|--------------------------------------------------------------------------------------------------------------------|

| (12)   | Represents $13,859 paid for health and dental insurance premiums in excess of coverage provided to other employees as well as $500,000 paid in severance payments paid to Zift Interactive, LLC., of which Mr. Sutton is the Manager and over whose securities he has voting and dispositive power. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (13)   | Represents $5,900 paid for health and dental insurance premiums in excess of coverage provided to other employees and $300,000 in severance payments. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| (14)   | Represents 23,295 shares at a grant date fair value of $0.68 per common share. |
|------------------|--------------------------------------------------------------------------------|

| (15)   | Represents 15,530 shares at a grant date fair value of $0.68 per common share and 30,000 shares at a grant date fair value of $1.20 per common share. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| (16)   | Represents 300,000 shares at a grant date fair value of $1.24 per common share. |
|------------------|---------------------------------------------------------------------------------|

| (17)   | Represents 400,000 shares at a grant date fair value of $1.24 per common share. |
|------------------|---------------------------------------------------------------------------------|

| (18)   | Represents 100,000 shares at a grant date fair value of $1.16 per common share. |
|------------------|---------------------------------------------------------------------------------|

| (19)   | Represents stock options to purchase 71,750 common shares at an exercise price of $0.68 per common share. |
|------------------|-----------------------------------------------------------------------------------------------------------|

| (20)   | Represents stock options to purchase 34,470 common shares at an exercise price of $0.68 per common share. |
|------------------|-----------------------------------------------------------------------------------------------------------|

| (21)   | Represents stock options to purchase 6,993 common shares at an exercise price of $1.43 per common share. |
|------------------|----------------------------------------------------------------------------------------------------------|

| (22)   | Represents 20,000 shares at a grant date fair value of $1.34 per common share. |
|------------------|--------------------------------------------------------------------------------|

----

----

| Name             |   | Shares |   |
|------------------|--------|--------|--------|
| Jesse Sutton     |   |   | 23,295 |   |
| Michael Vesey    |   |   | 15,530 |   |
| Laurence Aronson |   |   | 23,295 |   |
| Stephen Wilson   |   |   | 15,530 |   |
| Trent Davis      |   |   | 6,470  |   |
| Mohit Bhansali   |   |   | 6,470  |   |
| Adam Sultan      |   |   | 12,942 |   |

| Name             |   | Option Award |   |
|------------------|--------|--------------|--------|
| Jesse Sutton     |   |         | 71,705 |   |
| Michael Vesey    |   |         | 34,470 |   |
| Laurence Aronson |   |         | 71,705 |   |
| Stephen Wilson   |   |         | 64,470 |   |
| Trent Davis      |   |         | 56,030 |   |
| Mohit Bhansali   |   |         | 56,030 |   |
| Adam Sultan      |   |         | 12,058 |   |

----

| Name            |   | Shares |    |
|-----------------|--------|--------|---------|
| Barry Honig     |   |   | 400,000 |   |
| John Stetson    |   |   | 300,000 |   |
| Michael Brauser |   |   | 400,000 |   |
| Mohit Bhansali  |   |   | 25,000  |   |
| Edward Karr     |   |   | 50,000  |   |
| Andrew Kaplan   |   |   | 50,000  |   |

| Name             |   | Shares |   |
|------------------|--------|--------|--------|
| Michael Beeghley |   |   | 50,000 |   |

----

|                 |   | Option Awards                                                       |   | Stock Awards                                                          |
|----------------------|--------|---------------------------------------------------------------------|--------|-----------------------------------------------------------------------|
| Name                 |   | Number of Securities Underlying Unexercised Options Exercisable (#) |   | Number of Securities Underlying Unexercised Options Unexercisable (#) |   | Option Exercise Price($) |   | Option Expiration Date |   | Number of Shares or Units of Stock That Have Not Vested(#) |   | Market Value of Shares or Units of Stock That Have Not Vested($) (1.26)(1) |
| Barry Honig          |   |                                                                | --     |                                                                  |   |   | -- |   |   |   | -- |   |   | -- |   |   | 383,333 | (4) |   | $ | 483,000 |   |
| Michael Brauser      |   |                                                                | --     |                                                                  |   |   |   |   |   |   |   |   |   |   |   |   | 383,333 | (4) |   | $ | 483,000 |   |
| John Stetson         |   |                                                                | --     |                                                                  |   |   | -- |   |   |   | -- |   |   | -- |   |   | 287,500( | (4) |   | $ | 362,250 |   |
| David Rector         |   |                                                                | 6,993  | (2)                                                                   |   |   | -- |   |   | $ | 1.43 |   |   | July 27, 2020 |   |   | -- |   |   | $ | - |   |
| Michael Beeghley     |   |                                                                | --     |                                                                  |   |   |   |   |   |   | -- |   |   |   |   |   | - |   |   |   | - |   |
| Andrew Kaplan        |   |                                                                | --     |                                                                  |   |   | -- |   |   |   | -- |   |   |   |   |   | 47,917 | (4) |   | $ | 60,375 |   |
| Mohit Bhansali       |   |                                                                | 56,030 | (7)                                                                   |   |   |   |   |   | $ | 0.68 |   |   | December 31, 2021 |   |   | 23,958 | (4) |   | $ | 30,188 |   |
|                 |   |                                                                | 7,143  | (8)                                                                   |   |   |   |   |   | $ | 1.40 |   |   | April 30, 2020 |   |   |   |   |   |   |   |   |
| Edward Karr          |   |                                                                | --     |                                                                  |   |   |   |   |   |   | -- |   |   |   |   |   | 47,917 | (4) |   | $ | 60,375 |   |
| Trent Davis (4)      |   |                                                                | 71,705 | (9)                                                                   |   |   | -- |   |   | $ | 0.68 |   |   | December 31, 2021 |   |   | -- |   |   |   | -- |   |
|                 |   |                                                                | 7,143  | (11)                                                                  |   |   |   |   |   | $ | 1.40 |   |   | April 30, 2020 |   |   |   |   |   |   |   |   |
| Stephen Wilson (5)   |   |                                                                | --     |                                                                  |   |   | -- |   |   |   | -- |   |   | -- |   |   | -- |   |   |   | -- |   |
| Laurence Aronson (6) |   |                                                                | 2,323  | (9)                                                                   |   |   | -- |   |   | $ | 15.19 |   |   | August 1, 2016 |   |   | -- |   |   |   | -- |   |
|                 |   |                                                                | 1,880  |                                                                  |   |   |   |   |   | $ | 4.76 |   |   | August 1, 2017 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 1,961  |                                                                  |   |   |   |   |   | $ | 17.36 |   |   | August 1, 2018 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 2,579  |                                                                  |   |   |   |   |   | $ | 12.32 |   |   | August 2, 2019 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 7,559  |                                                                  |   |   |   |   |   | $ | 4.48 |   |   | August 3, 2020 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 15,848 |                                                                  |   |   |   |   |   | $ | 1.66 |   |   | August 3, 2021 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 71,705 |                                                                  |   |   |   |   |   | $ | 0.68 |   |   | March 28, 2022 |   |   |   |   |   |   |   |   |
|                 |   |                                                                | 7,143  |                                                                  |   |   |   |   |   | $ | 1.40 |   |   | April 23, 2020 |   |   |   |   |   |   |   |   |

| (1)   | The market value of the shares is determined by multiplying the number of shares times $1.26, the closing price of our common stock on The NASDAQ Capital Market on October 31, 2015, the last business day of our fiscal year. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | Option to purchase 6,993 common shares was exercisable on January 27, 2016. |
|-----------------|-----------------------------------------------------------------------------|

| (3)   | Vests at the end of each calendar month, at a rate of 1/24 of such shares per month. |
|-----------------|--------------------------------------------------------------------------------------|

| (4)   | Resigned on July 27, 2015 |
|-----------------|---------------------------|

| (5)   | Resigned on February 1, 2015 |
|-----------------|------------------------------|

| (6)   | Resigned on September 25, 2015 |
|-----------------|--------------------------------|

| (7)   | Option to purchase 56,030 common shares was exercisable on September 30, 2015 |
|-----------------|-------------------------------------------------------------------------------|

| (8)   | Option to purchase 7,143 common shares was exercisable on October 22, 2015 |
|-----------------|----------------------------------------------------------------------------|

| (9)   | Options to purchase 2,323 common shares exercisable on August 2011; options to purchase 1,880 common shares exercisable on August 2012; options to purchase 1,961 common shares exercisable on August 2013; options to purchase 2,579 common shares exercisable on August 2014; options to purchase 7,559 common shares exercisable on August 2015; options to purchase 15,848 common shares exercisable on September 25, 2015; options to purchase 71,705 common shares at $0.68 on September 25, 2015; and option to purchase 7,143 common shares was exercisable on September 25, 2015. |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | ● |  continued payment of his base salary on a regular payroll basis for a period of 12 months; |
|--------|---------|--------------------------------------------------------------------------------------------------|

|   | ● |  within 30 days of termination, a payment equal to the average of the percentages used to calculate Mr. Sutton’s Annual Incentive Cash Bonus (as such term is defined in the employment agreement) in each of the previous three fiscal years times Mr. Sutton’s then current base salary (the “Severance Bonus”); |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● |  acceleration and full vesting as of the date of termination of all unvested restricted stock, stock options and other equity awards held by Mr. Sutton at the time of such termination; and |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● |  continued Company contributions toward Mr. Sutton’s health care, dental, disability and life insurance benefits on the same basis as immediately prior to the date of termination for 12 months following the date of termination, unless Mr. Sutton is actually covered or becomes covered by an equivalent benefit (at the same cost to him, if any) from another source. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | ● |  within 30 days of termination, a payment in an amount equal to: (i) two years base salary; and (ii) the Severance Bonus; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------|

|   | ● |  acceleration and full vesting as of the date of termination of all unvested restricted stock, stock options and other equity awards held by Mr. Sutton at the time of such termination; and |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● |  continued Company contributions toward Mr. Sutton’s health care, dental, disability and life insurance benefits on the same basis as immediately prior to the date of termination for 12 months following the date of termination, unless Mr. Sutton is actually covered or becomes covered by an equivalent benefit (at the same cost to him, if any) from another source. |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | continued payment of his base salary on a regular payroll basis for a period of 12 months; |
|--------|---------|--------------------------------------------------------------------------------------------|

|   | ● | a bonus payment, which shall be an amount equal to his average “target” annual incentive opportunity over the prior three years and shall be payable immediately after the effective date of Mr. Vesey’s release; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | acceleration and full vesting as of the date of termination of all unvested restricted stock, stock options and other equity awards held by Mr. Vesey at the time of such termination; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | continued Company contributions toward Mr. Vesey’s health care, dental, disability and life insurance benefits on the same basis as immediately prior to the date of termination for 12 months following the date of termination, unless Mr. Vesey is actually covered or becomes covered by an equivalent benefit (at the same cost to him, if any) from another source. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | ● | continued payment of his base salary on a regular payroll basis for a period of 12 months; |
|--------|---------|--------------------------------------------------------------------------------------------|

|   | ● | a bonus payment, which shall be an amount equal to his average “target” annual incentive opportunity over the prior three years and shall be payable immediately after the effective date of Mr. Vesey’s release; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | acceleration and full vesting as of the date of termination of all unvested restricted stock, stock options and other equity awards held by Mr. Vesey at the time of such termination; and |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | continued Company contributions toward Mr. Vesey’s health care, dental, disability and life insurance benefits on the same basis as immediately prior to the date of termination for 12 months following the date of termination, unless Mr. Vesey is actually covered or becomes covered by an equivalent benefit (at the same cost to him, if any) from another source. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name                 |   | Fees Earned or Paid in Cash($) |   | StockAwards($)(1) |   | Option Awards($)(2) |    | All Other Compensation($) |   | Total($) |
|----------------------|--------|--------------------------------|--------|-------------------|--------|---------------------|---------|---------------------------|--------|----------|
| Barry Honig          |   |                           | -      |              |   |                | 496,000 | (6)                       |   |     |   |   |   |   | - |   |   |   | 496,000 |   |
| Michael Brauser      |   |                           | -      |              |   |                | 496,000 | (6)                       |   |     |   |   |   |   | - |   |   |   | 496,000 |   |
| Mohit Bhansali       |   |                           | 31,800 |              |   |                | 35,400  | (7)                       |   |     | 30,140 | (11) |   |   | - |   |   |   | 97,340 |   |
| Edward Karr          |   |                           | 5,000  |              |   |                | 62,000  | (8)                       |   |     |   |   |   |   | - |   |   |   | 67,000 |   |
| Andrew Kaplan        |   |                           | 5,000  |              |   |                | 62,000  | (8)                       |   |     |   |   |   |   | - |   |   |   | 67,000 |   |
| Michael Beeghley     |   |                           | 5,000  |              |   |                |    |                      |   |     |   |   |   |   | - |   |   |   | 5,000 |   |
| David Rector         |   |                           | -      |              |   |                | 116,000 | (9)                       |   |     | 6,273 | (12) |   |   | - |   |   |   | 122,273 |   |
| Trent Davis (3)      |   |                           | 31,000 |              |   |                | 4,400   | (10)                      |   |     | 30,140 | (11) |   |   | - |   |   |   | 65,540 |   |
| Stephen Wilson (4)   |   |                           | 12,500 |              |   |                | -       |                      |   |     | 30,546 | (13) |   |   | - |   |   |   | 43,046 |   |
| Laurence Aronson (5) |   |                           | 32,200 |              |   |                | -       |                      |   |     | 78,848 | (14) |   |   | - |   |   |   | 69,018 |   |

| (1)   | Represents the aggregate grant date fair value for stock awards granted by us in fiscal year 2015 computed in accordance with FASB ASC Topic 718. See Note 12 to our condensed consolidated financial statements reported in our Annual Report on Form 10-K for our fiscal year ended October 31, 2015 for details as to the assumptions used to determine the fair value of the stock awards. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2)   | Represents the aggregate grant date fair value of options granted in fiscal year 2015 computed in accordance with FASB ASC Topic 718. See Note 12 to our condensed consolidated financial statements reported in our Annual Report on Form 10-K for our fiscal year ended October 31, 2015 for details as to the assumptions used to determine the fair value of the option awards. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3)   | Resigned on July 27, 2015 |
|-----------------|---------------------------|

| (4)   | Resigned on February 1, 2015 |
|-----------------|------------------------------|

| (5)   | Resigned on September 25, 2015 |
|-----------------|--------------------------------|

| (6)   | Represents 400,000 shares at a grant date fair value of $1.24 per common share. |
|-----------------|---------------------------------------------------------------------------------|

| (7)   | Represents 6,470 shares at a grant date fair value of $0.68 per common share and 25,000 shares at a grant date fair value of $1.24 per common share. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8)   | Represents 50,000 shares at a grant date fair value of $1.24 per common share. |
|-----------------|--------------------------------------------------------------------------------|

| (9)   | Represents 100,000 shares at a grant date fair value of $1.16 per common share. |
|-----------------|---------------------------------------------------------------------------------|

| (10)   | Represents 6,470 shares at a grant date fair value of $0.68 per common share. |
|------------------|-------------------------------------------------------------------------------|

| (11)   | Represents stock options to purchase 56,030 common shares at an exercise price of $0.68 per common share and stock options to purchase 7,143common shares at an exercise price of $1.40 per common share. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (12)   | Represents stock options to purchase 6,993 common shares at an exercise price of $1.43 per common share. |
|------------------|----------------------------------------------------------------------------------------------------------|

| (13)   | Represents stock options to purchase 71,750 common shares at an exercise price of $0.68 per common share. |
|------------------|-----------------------------------------------------------------------------------------------------------|

| (14)   | Represents stock options to purchase 71,750 common shares at $0.68; and option to purchase 7,143 common shares at $1.40 per common share. |
|------------------|-------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name                 |   | Number of Stock Options Held at Fiscal Year-End |                                             | Number of Shares of Restricted Stock Held at Fiscal Year-End |
|----------------------|--------|-------------------------------------------------|--------------------------------------------------|--------------------------------------------------------------|
| Barry Honig          |   |                                            | --                                               |                                                         |   |   | 400,000 | (3) |
| Michael Brauser      |   |                                            |                                             |                                                         |   |   | 400,000 | (3) |
| Mohit Bhansali       |   |                                            | 56,030                                           | (1)                                                          |   |   | 25,000 | (3) |
|                 |   |                                            | 7,143                                            | (2)                                                          |   |   | 6,470( | (5) |
| Edward Karr          |   |                                            |                                             |                                                         |   |   | 50,000 | (3) |
| Andrew Kaplan        |   |                                            |                                             |                                                         |   |   | 50,000 | (3) |
| Michael Beeghley     |   |                                            |                                             |                                                         |   |   |   |   |
| David Rector         |   |                                            | 6,993                                            | (2)                                                          |   |   | 100,000 | (4) |
| Trent Davis (6)      |   |                                            |        56,030 | (1)                                                          |   |   | 6,470 | (5) |
| Stephen Wilson (7)   |   |                                            | --                                               |                                                         |   |   | -- |   |
| Laurence Aronson (8) |   |                                            | 2,323                                            | (9)                                                          |   |   | -- |   |
|                 |   |                                            | 1,880                                            | (10)                                                         |   |   |   |   |
|                 |   |                                            | 1,961                                            | (11)                                                         |   |   |   |   |
|                 |   |                                            | 2,579                                            | (12)                                                         |   |   |   |   |
|                 |   |                                            | 7,559                                            | (13)                                                         |   |   |   |   |
|                 |   |                                            | 15,848                                           | (14)                                                         |   |   |   |   |
|                 |   |                                            | 71,705                                           | (15)                                                         |   |   |   |   |
|                 |   |                                            | 7,143                                            | (16)                                                         |   |   |   |   |

| (1)   | Options to purchase 56,030 common shares at $0.68 per share became exercisable on September 30, 2015.  |
|-----------------|-------------------------------------------------------------------------------------------------------------|

| (2)   | Options to purchase 7,143 common shares at $1.40 per shares became exercisable on January 27, 2016.  |
|-----------------|-----------------------------------------------------------------------------------------------------------|

| (3)   | Vests at the end of each calendar month, at a rate of 1/24 of such shares per month, starting on the grant date of September 30, 2015.  |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| (4)   | Represents a restricted stock grant given to Mr. Rector on August 28, 2015, which was originally scheduled to vest in three equal installments on the first, second and third anniversaries of the grant date or upon a change in control of the Company, provided Mr. Rector was serving as Chief Executive Officer. The vesting schedule was accelerated, and the 100,000 shares vested in full on January 12, 2016.  |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5)   | Shares vested on September 30, 2015.  |
|-----------------|--------------------------------------------|

| (6)   | Resigned on July 27, 2015  |
|-----------------|---------------------------------|

| (7)   | Resigned on February 1, 2015  |
|-----------------|------------------------------------|

| (8)   | Resigned on September 25, 2015  |
|-----------------|--------------------------------------|

| (9)   | Options to purchase 2,323 common shares at $17.36 per share became fully exercisable on August 3, 2011.  |
|-----------------|---------------------------------------------------------------------------------------------------------------|

| (10)   | Options to purchase 1,880 common shares at $4.76 per shares became fully exercisable on August 3, 2012.  |
|------------------|---------------------------------------------------------------------------------------------------------------|

| (11)   | Options to purchase 1,961 common shares at $17.36 per shares became fully exercisable on August 3, 2013.  |
|------------------|----------------------------------------------------------------------------------------------------------------|

| (12)   | Options to purchase 2,579 common shares at $12.32 per shares became fully exercisable on August 3, 2014.  |
|------------------|----------------------------------------------------------------------------------------------------------------|

| (13)   | Options to purchase 7,559 common shares at $4.48 per shares became fully exercisable on August 3, 2015.  |
|------------------|---------------------------------------------------------------------------------------------------------------|

| (14)   | Options to purchase 15,848 common shares at $1.66 per shares became fully exercisable upon resignation, September 25, 2015.  |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------|

| (15)   | Options to purchase 71,705 common shares at $0.68 per share became exercisable upon resignation, September 25, 2015.  |
|------------------|----------------------------------------------------------------------------------------------------------------------------|

| (16)   | Options to purchase 7,143 common shares at $1.40 per share became exercisable upon resignation, September 25, 2015. |
|------------------|---------------------------------------------------------------------------------------------------------------------|

----

| Common Stock                                                   |   | Number of Shares of Common Stock Beneficially Owned |      | Percentage of Common Stock |
|----------------------------------------------------------------|--------|-----------------------------------------------------|-----------|----------------------------|
| Greater than 5% Holders:                                       |   |                                                |      |                       |   |   |   |
| Melechdavid Inc. (1)                                           |   |                                                | 736,048   |  (2)                  |   |   | 6.18% |   |
| 5154 La Gorce DriveMiami Beach, FL 33140                       |   |                                                |      |                       |   |   |   |   |
| Executive Officers and Directors:                              |   |                                                |      |                       |   |   |   |   |
| Barry Honig (3)                                                |   |                                                | 607,570   |  (4)                  |   |   | 5.10% |   |
| Michael Brauser (5)                                            |   |                                                | 559,435   |  (6)                  |   |   | 4.69% |   |
| John Stetson (7)                                               |   |                                                | 281,059   |  (8)                  |   |   | 2.36% |   |
| David Rector                                                   |   |                                                | 106,993   | (9)                        |   |   | * |   |
| Michael Beeghley                                               |   |                                                | 6,250     | (10) (11)                  |   |   | * |   |
| Andrew Kaplan                                                  |   |                                                | 12,500    | (10)                       |   |   | * |   |
| Mohit Bhansali                                                 |   |                                                | 69,423    | (12)(13)                   |   |   | * |   |
| Edward Karr                                                    |   |                                                | 12,500    | (10)                       |   |   | * |   |
| Current Executive Officers and Directors as a Group(8 persons) |   |                                                | 1,655,730 |                       |   |   | 13.81% |

|   | * | Represents beneficial ownership of less than 1% of the shares of common stock. |
|--------|---|--------------------------------------------------------------------------------|

----

| (1) | Mark Groussman is the President of Melechdavid Inc. and the Trustee of Melechdavid Inc. Retirement Plan and in such capacity he is deemed to hold voting and dispositive power over the securities held by such entities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | Based solely on review of the holder's Schedule 13G filed with the SEC on July 9, 2015, includes 678,348 shares held by Melechdavid Inc. and 57,700 shares held by Melechdavid Inc. Retirement Plan. Excludes 485,294 shares of common stock underlying Series A Convertible Preferred Stock, 346,640 shares of common stock underlying Series B Preferred Stock, 666,667 shares of common stock underlying Series C Convertible Preferred Stock and 666,667 shares of common stock underlying warrants held by Melechdavid Inc. Each of the forgoing classes of preferred stock and the warrants contains an ownership limitation such that the holder may not convert or exercise, as applicable, any of such securities to the extent that such conversion or exercise, as applicable, would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates. Excludes 367,648 shares of common stock underlying Series A Convertible Preferred Stock and 262,606 shares of common stock underlying Series B Convertible Preferred Stock held by Melechdavid Inc. Retirement Plan.  Each of the forgoing classes of preferred stock contains an ownership limitation such that the holder may not convert any of such securities to the extent that such conversion would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| (3) | Barry Honig is the Trustee of GRQ Consultants, Inc. 401K and GRQ Consultants, Inc. Roth 401K FBO Barry Honig, and he is a Manager of Marlin Capital Investments, LLC. In such capacities he is deemed to hold voting and dispositive power over the securities held by such entities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (4) | Based solely on a review of the holder’s Schedule 13D filed with the SEC on October 13, 2015, includes 357,889 shares of common stock held by Barry Honig, of which 100,000 shares represent the vested portion (including shares vesting within 60 days) of a 400,000 share restricted stock award under our 2014 Equity Incentive Plan approved by the Company’s shareholders, and which vest at a rate of 1/24 of such award shares per month or upon a Qualified Transaction as defined in the award. Includes 91,076 shares of common stock held by GRQ Consultants, Inc. 401K, and 110,470 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig. Excludes 2,205,883 shares of common stock underlying shares of Series A Convertible Preferred Stock held by Mr. Honig, and 1,575,600 shares of common stock underlying shares of Series B Convertible Preferred Stock held by Mr. Honig.  Each of the forgoing classes of preferred stock contains an ownership limitation such that the holder may not convert any of such securities to the extent that such conversion would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates. Excludes 154,657 shares of common stock underlying shares of Series A Convertible Preferred Stock and 833,334 shares of common stock underlying shares of Series C Convertible Preferred Stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig; 117,648 shares of common stock underlying shares of Series A Convertible Preferred Stock and 84,000 shares of common stock underlying Series B Convertible Preferred Stock held by Marlin Capital Investments, LLC; and 833,334 shares of common stock underlying shares of Series C Convertible Preferred Stock and 333,333 shares of Common Stock underlying shares of Series D Convertible Preferred Stock held by GRQ Consultants, Inc. 401K.  Each of the forgoing classes of preferred stock contains an ownership limitation such that the holder may not convert any of such securities to the extent that such conversion would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates.  |
| (5) | Michael Brauser is Chairman of the Betsy & Michael Brauser Charitable Family Foundation, Trustee of Grander Holdings, Inc. 401K and a Manager of Marlin Capital Investments, LLC. In such capacities he is deemed to hold voting and dispositive power over the securities held by such entities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

----

| (6)    | Based solely on a review of the holder’s Schedule 13D filed with the SEC on October 13, 2015, includes 100,100 shares of common stock held by Michael Brauser, of which 100,000 shares represent the vested portion (including shares vesting within 60 days) of a 400,000 share restricted stock award under the 2014 Equity Incentive Plan approved by our shareholders, and which vest at a rate of 1/24 of such award shares per month or upon a Qualified Transaction, as defined in the award. Excludes 2,205,883 shares of common stock underlying Series A Convertible Preferred Stock and 1,575,630 shares of Common Stock underlying shares of Series B Convertible Preferred Stock held by Michael Brauser. Each of the forgoing classes of preferred stock contains an ownership limitation such that the holder may not convert any of such securities to the extent that such conversion would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates. Includes 235,786 shares of common stock held by Michael & Betsey Brauser TBE, 125,000 shares of Common Stock held by Betsy & Michael Brauser Charitable Family Foundation, and 146,684 shares of common stock held by Grander Holdings, Inc. 401K.  |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (7)    | John Stetson is President of Stetson Capital Investments, Inc. and Stetson Capital Investments, Inc. Retirement Plan. In such capacities he is deemed to hold voting and dispositive power over the securities held by such entities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (8)    | Includes 114,391 shares of common stock, of which 75,000 shares represent the vested portion (including shares vesting within 60 days) of a 300,000 share restricted stock award under the 2014 Equity Incentive Plan approved by the Company’s shareholders, and which vest at a rate of 1/24 of such award shares per month or upon a Qualified Transaction as defined in the award. Includes 83,334 shares of common stock held by Stetson Capital Investments and 83,334 shares of common stock held by Stetson Capital Investments, Inc. Retirement Plan. Excludes 55,147 shares of common stock underlying Series A Preferred Stock and 66,660 shares of common stock underlying Series D Preferred Stock. Each of the forgoing classes of preferred stock contains an ownership limitation such that the holder may not convert any of such securities to the extent that such conversion would result in the holder’s beneficial ownership being in excess of 4.99% of the Company’s issued and outstanding common stock together with all shares owned by the holder and its affiliates.                                                                                                                                                                                                                                                                   |
| (9)    | Includes 100,000 common shares and options to purchase 6,993 shares of common stock that are exercisable within 60 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (10)   | Includes 12,500 shares which represent the vested portion (including shares vesting within 60 days) of a 50,000 share restricted stock grant which vests at the end of each calendar month at a rate of 1/24 of such shares per month.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| (11)   | Includes 6,250 shares which represent the vested portion (including shares vesting within 60 days) of a 50,000 share restricted stock grant which vests at the end of each calendar month at a rate of 1/24 of such shares per month.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (12)   | Includes 6,250 shares which represent the vested portion (including shares vesting within 60 days) of a 25,000 shares of restricted stock grant which vests at the end of each calendar month at a rate of 1/24 of such shares per month.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (13)   | Includes options to purchase 63,173 shares of common stock that are exercisable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

----

| Plan category                                              |   | Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights (#) |    | Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights ($) |   | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (#) |
|------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------|---------|---------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                  |   | (a)                                                                                             |    | (b)                                                                             |   | (c)                                                                                                                                             |
| Equity compensation plans approved by security holders     |   |                                                                                            | 579,485 |                                                                            |   | $                                                                                                                                               | 2.82 |   |   |   | 596,992 |   |
| Equity compensation plans not approved by security holders |   |                                                                                            | -0-     |                                                                            |   |                                                                                                                                            | -0- |   |   |   | -0- |   |
| Total                                                      |   |                                                                                            | 579,485 |                                                                            |   | $                                                                                                                                               | 2.82 |   |   |   | 596,992 |   |

----

|               |   | 2015   |    |   | 2014   |   |
|--------------------|--------|--------|---------|--------|--------|--------|
| Audit Fees         |   | $      | 139,900 |   |   | $      | 177,500 |   |
| Audit Related Fees |   |   | 11,300  |   |   |   | 18,375 |   |
| Tax Fees           |   |   | --      |   |   |   | -- |   |
| Other Fees         |   |   | --      |   |   |   | -- |   |
| Total Fees         |   | $      | 151,200 |   |   | $      | 195,875 |   |

----

|   | ● | reviewed and discussed the audited financial statements for the fiscal year ended October 31, 2015 with management and EisnerAmper LLP (“EisnerAmper”), our independent public accountant; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ●  | discussed with EisnerAmper the matters required to be discussed in accordance with the rules set forth by the Public Company Accounting Oversight Board (“PCAOB”), relating to the conduct of the audit; and |
|--------|---------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ●  | received written disclosures and the letter from EisnerAmper regarding its independence as required by applicable requirements of the PCAOB regarding EisnerAmper’s communications with the Audit Committee and the Audit Committee further discussed with EisnerAmper its independence. The Audit Committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and audit process that the Audit Committee determined appropriate. |
|--------|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | MAJESCO ENTERTAINMENT COMPANY AND SUBSIDIARYBy:    /s/ Barry HonigBarry Honig, Chief Executive Officer (Principal Executive Officer)Date: February 26, 2016By:    /s/ John StetsonJohn Stetson, Chief Financial Officer (Principal Financial and Accounting Officer)Date: February 26, 2016 |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Signature                                  | Title                                                                                                | Date              |
|--------------------------------------------|------------------------------------------------------------------------------------------------------|-------------------|
|                                       |                                                                                                 |              |
| /s/ Barry HonigBarry Honig                 | Chief Executive Officer and Co-Chairman of the Board of Directors(Principal Executive Officer)  | February 26, 2016 |
| /s/ John StetsonJohn Stetson          | Chief Financial Officer (Principal Financial and Accounting Officer)                            | February 26, 2016 |
| /s/ Michael BrauserMichael Brauser    | Co-Chairman of the Board of Directors                                                           | February 26, 2016 |
| /s/ Michael BeeghleyMichael Beeghley  | Director                                                                                             | February 26, 2016 |
| /s/ Mohit BhansaliMohit Bhansali      | Director                                                                                             | February 26, 2016 |
| /s/ Andrew KaplanAndrew Kaplan        | Director                                                                                             | February 26, 2016 |
| /s/ Edward KarrEdward Karr            | Director                                                                                             | February 26, 2016 |
| /s/ David RectorDavid Rector               | Director                                                                                             | February 26, 2016 |

----